Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infection surveillance solutions are used to reduce several healthcare associated infections such as pneumonia (eg, ventilator-associated pneumonia [VAP]), bloodstream infection (BSI), urinary tract infection (UTI), and surgical site infection (SSI). It is also used to reduce other infections such as surgical wound infections, respiratory tract infections, and many others. A healthcare-associated infection is an infection whose development is favored by a hospital or other healthcare facilities environment, such as one acquired by a patient during a hospital visit
Primary driving factors such as the vast presence of developing as well as developed economies, increasing funding for improving the healthcare infrastructure and redevelopment of healthcare projects and surged demand to limit healthcare costs are attributed to the growth of the market in Europe. In addition, increasing necessity to prevent HAIs in hospitals, increased use of infection surveillance solutions, and aging elderly population and thus rising hospitalization are creating more demand for infection surveillance solutions in the Europe.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the infection surveillance solutions market. In addition, complete analysis of changes on infection surveillance solutions market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increasing number of hospitals and clinical laboratories for the diagnosis and the detection of the COVID-19 patient is improving the growth of infection surveillance solutions market. High-throughput technologies are being leveraged by a growing number of hospitals to prevent and control healthcare associated as well as COVID-19 infection spread effectively and rapidly on a wide scale.
The study analyses Europe infection surveillance solutions market based on product, end user and country.
Based on product, the Europe infection surveillance solutions market segmented into software and services segment. The software segment dominated the market in 2021 and is likely to witness rapid growth during the forecast period. The software segment is further sub-segmented into on-premise and web-based. A surged demand for web-based software solutions owing to its benefits such as low cost, intuitive, easy use, and ability to operate in real time is likely to propel growth of the segment in the coming years. Moreover, major services such as product support & maintenance services, training & consulting services and implementation services are analyzed in the market.
Major end users of Europe infection surveillance solutions market are hospitals, long-term care facilities, others. Hospitals is expected to gain major market share during the forecast period (2019-2028). The hospitals segment include sub-segments such as large hospitals, medium-sized hospitals and small hospitals. An increasing adoption of advanced technologies in hospital for maintaining records, reports, data, and surgeries data using various products to enhance the patient treatment is attributed to the segment growth. However, long-term care facilities segment is anticipated to account for second largest share in the market during the projected timeframe.
Country wise, the study is comprised of the key countries such as the UK, Germany, France, Italy, Spain and rest of Europe. Germany held the largest market share of Europe infection surveillance solutions market and is likely to dominate the market over the estimated time frame. Rise in health care spending and increase in number of healthcare facilities such as hospitals and ambulatory surgical centres are the key factors driving the market growth in Germany. For instance, as per the Germany Trade and Invest, in the country, healthcare expenditure exceeds EUR 400 billion in 2019 (USD 471.14 Bn). And there were approximately 1,925 hospitals in 2018.
The major key players of market includes Becton Dickson & Company (United States), Baxter International Inc (United States), Premier Inc (United States), Wolters Kluwer N.V (Netherlands), Gojo Industries, Inc (United States), RL Solutions (United States), Truven Health Analytics (An IBM Company) (United States), DEB Group Ltd (United Kingdom), Hygreen, Inc (United States), Vigilanz Corporation (United States), Cerner Corporation (United States), Epic Systems Corporation (United States), Vecna Technologies (United States), Emerald Health Information System (Canada), Medexter Healthcare (Austria), and PeraHealth Inc (United States) among others.
October 2020: RLDatix, the global provider of intelligent patient safety solutions, acquired Verge Health, the recognized best-in-class credentialing software provider. This acquisition joins two companies in the governance, risk, and compliance healthcare software market and dramatically accelerated an essential shift from a reactive approach to risk management to one rooted in safety and prevention.
September 2018: Wolters Kluwer N.V launched the clinical surveillance solution Sentri7. This solution gives hospital tools and resources to stay in front of new challenges and battle the anti-biotic resistant bacteria.
The study analyses Europe infection surveillance solutions market based on product, end user, and country. Based on product, the Europe infection surveillance solutions market segmented into software and services segment. The software segment is likely to dominate the market over the forecast period. Increased adoption of infection surveillance software solutions in end use industries owing to its several benefits is attributed to the market growth. Major end users of Europe infection surveillance solutions market are hospitals, long-term care facilities, others. The hospitals segment is likely to register fastest growth in years to come owing to the increasing number of hospital admissions every year. Country wise, the study is comprised of the key countries such as the UK, Germany, France, Italy, Spain and rest of Europe.
Why to buy this report:
